<figure><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iGFlodTg9T7M/v7/-1x-1.png"><figcaption><div></div><div></div></figcaption></figure><p>Asensus Surgical plans to develop augmented intelligence capabilities that digitize surgery to lower variabilities during procedures, drive better results and ultimately expand the adoption of robotics, CEO Anthony Fernando says. In this episode of Bloomberg Intelligence&#x2019;s Vanguards of Health Care podcast, Fernando sits down with BI health care analyst Matt Henriksson to discuss Asensus, the current barriers that keep robotic surgery&#x2019;s penetration rates low and its pending acquisition by Karl Storz. Asensus&#x2019; product pathway includes the next-generation Luna robotic system, including TrueWrist 5mm instruments as well as enhancements to its Intelligent Surgical Unit.</p>

Asensus Surgical has several developments as it plans to develop augmented intelligence capabilities that digitizes surgery to lower variabilities during procedures, drive better results, and ultimately expand adoption of robotics, CEO Anthony Fernando explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Fernando sits down with BI analyst Matt Henriksson for an in-depth interview on Asensus, the current barriers that have kept penetration rates of robotic surgery low, and its pending acquisition by Karl Storz.  Its product pathway includes its next-generation Luna robotic system, including TrueWrist 5mm instruments as well as enhancements to its ISU (short for Intelligent Surgical Unit).

Asensus Bridges Digital to Surgery: Vanguards of Health Care

Hub Poster

Understand every aspect of the global economy – and know how to make your next move.